Mostrar el registro sencillo del ítem

dc.contributor.authorMarin-Jimenez, Ignacio
dc.contributor.authorCasellas, Francesc
dc.contributor.authorCortes, Xavier
dc.contributor.authorGarcia-Sepulcre, Mariana F
dc.contributor.authorJulia, Berta
dc.contributor.authorCea-Calvo, Luis
dc.contributor.authorSoto, Nadia
dc.contributor.authorNavarro-Correal, Ester
dc.contributor.authorSaldana, Roberto
dc.contributor.authorDe Toro Santos, Francisco Javier 
dc.contributor.authorGalindo, Maria J
dc.contributor.authorOrozco-Beltran, Domingo
dc.date.accessioned2022-01-25T12:18:56Z
dc.date.available2022-01-25T12:18:56Z
dc.date.issued2019
dc.identifier.issn0025-7974
dc.identifier.otherhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456160/pdf/medi-98-e15044.pdfes
dc.identifier.otherhttps://www.ncbi.nlm.nih.gov/pubmed/30946348es
dc.identifier.urihttp://hdl.handle.net/20.500.11940/15945
dc.description.abstractTo assess inflammatory bowel disease (IBD) patients' experience of chronic illness care and the relationship with demographic and healthcare-related characteristics.This cross-sectional survey used the Instrument to Evaluate the EXperience of PAtients with Chronic diseases (IEXPAC) questionnaire to identify parameters associated with a better healthcare experience for IBD patients. IEXPAC questionnaire responses are grouped into 3 factors - productive interactions, new relational model, and patient self-management, scoring from 0 (worst) to 10 (best experience). Scores were analyzed by bivariate comparisons and multiple linear regression models.Surveys were returned by 341 of 575 patients (59.3%, mean age 46.8 (12.9) years, 48.2% women). Mean (SD) IEXPAC score was 5.9 (2.0); scores were higher for the productive interactions (7.7) and patient self-management factors (6.7) and much lower for the new relational model factor (2.2). Follow-up by a nurse, being seen by the same physician, and being treated with a lower number of medicines were associated with higher (better) overall patient experience score, and higher productive interactions and self-management factor scores. A higher productive interactions score was also associated with patients receiving medication subcutaneously or intravenously. Higher new relational model scores were associated with follow-up by a nurse, affiliation to a patients' association, receiving help from others for healthcare, a lower number of medicines and a higher educational level.In patients with IBD, a better overall patient experience was associated with follow-up by a nurse, being seen by the same physician, and being treated with a lower number of medicines.en
dc.language.isoenges
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshAdult*
dc.subject.meshMiddle Aged*
dc.subject.meshInflammatory Bowel Diseases*
dc.subject.meshHumans*
dc.subject.meshCross-Sectional Studies*
dc.subject.meshLinear Models*
dc.subject.meshProfessional-Patient Relations*
dc.subject.meshChronic Disease*
dc.subject.meshLong-Term Care*
dc.titleThe experience of inflammatory bowel disease patients with healthcare: A survey with the IEXPAC instrument.en
dc.typeArtigoes
dc.identifier.doi00005792-201904050-00040 [pii]
dc.identifier.pmid30946348
dc.identifier.sophos32534
dc.issue.number14es
dc.journal.titleMEDICINEes
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario de A Coruña::Reumatoloxíaes
dc.rights.accessRightsopenAccesses
dc.subject.decsrelaciones profesional-paciente*
dc.subject.decsmodelos lineales*
dc.subject.decsenfermedad inflamatoria intestinal*
dc.subject.decsenfermedad crónica*
dc.subject.decsmediana edad*
dc.subject.decshumanos*
dc.subject.decsestudios transversales*
dc.subject.decsadulto*
dc.subject.decsasistencia a largo plazo*
dc.subject.keywordCHUACes
dc.typefidesArtículo Originales
dc.typesophosArtículo Originales
dc.volume.number98es


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 International
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 International